Karyopharm Therapeutics Inc. short interest in 2022
In 2022, Karyopharm Therapeutics Inc.'s disclosed short interest ran from 15.50% of shares outstanding on 14 Jan 2022 to 25.76% on 30 Dec 2022, a change of +10.26 percentage points. The year's high was 25.76% on 30 Dec 2022 and its low 14.45% on 15 Mar 2022, averaging 18.23% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.71 days on 30 Nov 2022. Full history: Karyopharm Therapeutics Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 15.50% (14 Jan 2022)
- End of year
- 25.76% (30 Dec 2022)
- Change
- +10.26 pp
- High
- 25.76% (30 Dec 2022)
- Low
- 14.45% (15 Mar 2022)
- Average
- 18.23%
- Highest days to cover
- 11.71 (30 Nov 2022)
- SEC filings marked
- 9
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 15.50% | 5.43 | results (8-K) |
| 31 Jan 2022 | 15.10% | 4.93 | |
| 15 Feb 2022 | 14.58% | 2.43 | results (8-K) |
| 28 Feb 2022 | 15.78% | 1.83 | |
| 15 Mar 2022 | 14.45% | 2.87 | 10-K filed |
| 31 Mar 2022 | 17.49% | 4.31 | |
| 14 Apr 2022 | 16.99% | 5.33 | |
| 29 Apr 2022 | 17.57% | 7.55 | |
| 13 May 2022 | 18.35% | 4.52 | 10-Q filed, results (8-K) |
| 31 May 2022 | 18.22% | 6.51 | |
| 15 Jun 2022 | 19.33% | 6.70 | |
| 30 Jun 2022 | 20.58% | 5.21 | |
| 15 Jul 2022 | 22.77% | 9.07 | |
| 29 Jul 2022 | 22.52% | 10.04 | |
| 15 Aug 2022 | 21.34% | 8.01 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 18.91% | 8.47 | |
| 15 Sep 2022 | 17.86% | 7.86 | |
| 30 Sep 2022 | 16.84% | 7.32 | |
| 14 Oct 2022 | 17.16% | 9.18 | |
| 31 Oct 2022 | 16.66% | 8.31 | |
| 15 Nov 2022 | 16.81% | 5.63 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 16.79% | 11.71 | |
| 15 Dec 2022 | 20.24% | 6.00 | |
| 30 Dec 2022 | 25.76% | 6.30 |
See also: Karyopharm Therapeutics Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.